Antiperspirant Above Dermaclinical Men Aerosol, Spray
FDA Label NDC 73306-1144

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Baston Industria De Aerossois Ltda for the product Antiperspirant Above Dermaclinical Men (NDC 73306-1144). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding aluminum sesquichlorohydrate 16%, antiperspirant, email : [email protected] or call (305) 677-5030, reduces underarms wetness, butane propane isobutane cyclopentasiloxane isopropyl myristate c12-15 alkyl benzoate parfum quaternium-18 hectorite cyclohexasiloxane propylene carbonate aluminum starch octenylsuccinate 2-methyl 5-cyclohexylpentanol tocopheryl acetate aqua gossypium herbaceum seed oil allantoin butyrospermum parkii butter macadamia ternifolia seed oil cocos nucifera fruit extract chamomilla recutita flower extract aloe barbadensis leaf extract camellia sinensis leaf extract cinnamomum zeylanicum bark extract acorus calamus root extract commiphora myrrha resin extract olea europaea fruit oil argania spinosa kernel oil lecithin polyglyceryl-3 diisostearate glycerin glyceryl stearate, warnings and precautions, warnings, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.